Trial Profile
A Phase 1b, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Pharmacokinetics, Safety and Efficacy of ARRY-371797 [ARRY-797] in Patients With Rheumatoid Arthritis (RA) Receiving Stable Doses of Methotrexate (MTX).
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Emprumapimod (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Biomarker; Pharmacokinetics; Therapeutic Use
- Sponsors Array BioPharma
- 09 Jul 2009 Results reported in a Array BioPharma media release.
- 01 May 2009 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.
- 01 May 2009 Actual number of patients (28) added as reported by ClinicalTrials.gov